Cerenome, Inc.
CNSY
$2.49
-$0.21-7.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -20.95% | -0.46% | -10.49% | -8.16% | -3.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.95% | -0.46% | -10.49% | -8.16% | -3.49% |
| Cost of Revenue | 55.44% | -0.89% | -20.80% | -31.86% | -25.66% |
| Gross Profit | -204.29% | 1.40% | 33.43% | 56.69% | 48.65% |
| SG&A Expenses | 80.17% | 37.96% | 22.06% | 20.67% | 14.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.17% | 19.49% | -0.04% | -8.17% | -7.77% |
| Operating Income | -106.69% | -26.45% | -4.10% | 8.17% | 9.44% |
| Income Before Tax | -37.11% | 56.00% | -72.49% | -59.69% | -43.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -37.11% | 56.00% | -72.49% | -59.69% | -43.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.11% | 56.00% | -72.49% | -59.69% | -43.82% |
| EBIT | -106.69% | -26.45% | -4.10% | 8.17% | 9.44% |
| EBITDA | -116.15% | -31.40% | -7.45% | 8.37% | 10.89% |
| EPS Basic | 99.42% | 99.68% | -1,329.38% | -1,141.06% | -894.60% |
| Normalized Basic EPS | 99.55% | 99.95% | -1,745.72% | -1,497.08% | -1,176.87% |
| EPS Diluted | 99.42% | 99.58% | -1,169.79% | -1,020.75% | -817.49% |
| Normalized Diluted EPS | 99.55% | 99.75% | -1,924.41% | -1,628.00% | -1,259.08% |
| Average Basic Shares Outstanding | 804.10% | 1,927.13% | 1,007.50% | 608.19% | 248.11% |
| Average Diluted Shares Outstanding | 159.06% | 2,204.89% | 1,377.09% | 1,084.92% | 888.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |